Portfolio Lab

Alkermes plc.

  • Stock
  • Ticker ALKS
  • ISIN IE00B56GVS15
  • Nasdaq
  • US listing in dollars

Health care · Pharmaceuticals · Other countries

$44.94 −2.69%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Alkermes plc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

ALKSGlobal equities (VT)

$10,000 grew to $7,591. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −80.6% in 03/2020, measured from the peak in 02/2018. The old peak has not been reached again yet.

1-year return
+59.4%
5-year return p.a.
+14.1%
10-year return p.a.
−2.7%
Volatility p.a.
35.9%
Largest decline
−80.6%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue430307391394385393496480
Gross profit368257341343338331398386
Operating income16314938958-481836
EBITDA170211019762-294963
Net income14722878349-660.516
Earnings per share0.870.130.520.490.29-0.400.000.09
Balance sheet
Total assets2,0562,0822,2532,3302,4874,2584,3934,436
Liabilities5915706285966682,5072,5852,571
Equity1,4651,5121,6251,7331,8191,7521,8091,865
Cash291400521616389352512631
Long-term debt––––0.01,4841,4771,471
Cash flow
Operating cash flow19099150102170-16614593
Capital expenditure-9.8-10-13-170.0-4.1-8.1-3.4
Free cash flow1818913784170-17013790

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2021 at +16.6%, weakest 2018 at −46.1%. 4 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
3 Nov 2026$0.09
28 Jul 2026$0.00
5 May 2026−$0.40
25 Feb 2026$0.29
28 Oct 2025$0.49
29 Jul 2025$0.52
1 May 2025$0.13
12 Feb 2025$0.87
24 Oct 2024$0.55
24 Jul 2024$0.53
1 May 2024$0.21
21 Feb 2024$0.68

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€6.8bn
Market cap in trading currency
$7.55bn
Enterprise value
$8.31bn
P/E
–
P/S
4.31
P/B
4.05
EV/Sales
4.74
EV/EBITDA
57.3
Earnings yield
–
FCF yield
3.0%

Results (last four quarters)

Revenue
$1.75bn
Gross profit
$1.45bn
EBITDA
$145m
Net income
−$351,000
Earnings per share
−$0.02
Revenue per share
$10.44
Revenue growth
+21.8%
Earnings growth
−80.3%

Profitability

Gross margin
82.9%
Operating margin
3.7%
Net margin
0.0%
Return on equity
0.0%
Return on assets
0.0%

Balance sheet and cash flow

Cash
$755m
Cash per share
$4.50
Financial debt
$1.51bn
Debt/equity %
81
Current ratio
2.42
Book value per share
$11.10
Operating cash flow
$243m
Free cash flow
$227m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
168m
Volume
1.07m
Avg. volume 3 months
1.91m
Relative volume
0.6

Price and technicals

Price
$44.94
1 day
−2.7%
52-week high
$55.22
52-week low
$27.20
Distance to 52-week high
−18.6%
Distance to 52-week low
+65.2%
Distance to 50-day line
+2.9%
Distance to 200-day line
+8.5%
RSI (14)
49
Volatility 1M
29.8%

Performance

1 week
−4.4%
1 month
+1.7%
3 months
−8.0%
6 months
+22.1%
YTD
+60.6%
1 year
+56.6%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has ALKS performed since 11/2016?

$10,000 grew to $7,591 by 20 Nov 2026, which is −2.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is ALKS?

Volatility was 35.9% per year, measured on monthly returns. The largest decline from a peak was −80.6%, with the low in 03/2020.

How does ALKS compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ALKS returned −2.7% at 35.9%. The correlation of monthly returns was 0.30; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Why does this page show a US listing?

The figures use the stock's listing traded in the US. On individual days its path differs slightly from the price on the home exchange.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Alkermes plc. (ALKS): Return and risk | Portfolio Lab